Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | -0.40% | |
| Pocket Pivot | Bullish Swing Setup | -0.40% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| Outside Day | about 16 hours ago |
| Down 3% | about 16 hours ago |
| Fell Below Previous Day's Low | about 16 hours ago |
| Down 2 % | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.745 |
| 52 Week Low | 4.97 |
| Average Volume | 5,418,073 |
| 200-Day Moving Average | 9.02 |
| 50-Day Moving Average | 9.27 |
| 20-Day Moving Average | 8.45 |
| 10-Day Moving Average | 9.07 |
| Average True Range | 0.71 |
| RSI (14) | 65.16 |
| ADX | 19.59 |
| +DI | 31.63 |
| -DI | 13.05 |
| Chandelier Exit (Long, 3 ATRs) | 8.53 |
| Chandelier Exit (Short, 3 ATRs) | 9.27 |
| Upper Bollinger Bands | 9.97 |
| Lower Bollinger Band | 6.93 |
| Percent B (%b) | 1.01 |
| BandWidth | 35.99 |
| MACD Line | 0.15 |
| MACD Signal Line | -0.12 |
| MACD Histogram | 0.2732 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.49 | ||||
| Resistance 3 (R3) | 11.54 | 11.10 | 11.24 | ||
| Resistance 2 (R2) | 11.10 | 10.73 | 11.08 | 11.16 | |
| Resistance 1 (R1) | 10.56 | 10.49 | 10.34 | 10.50 | 11.08 |
| Pivot Point | 10.12 | 10.12 | 10.01 | 10.09 | 10.12 |
| Support 1 (S1) | 9.57 | 9.74 | 9.35 | 9.52 | 8.94 |
| Support 2 (S2) | 9.13 | 9.51 | 9.11 | 8.86 | |
| Support 3 (S3) | 8.59 | 9.13 | 8.78 | ||
| Support 4 (S4) | 8.53 |
